A case of extrahepatic bile duct cancer with distant metastases showing pathological complete response to treatment combining gemcitabine and cisplatin

被引:8
作者
Adachi, Kai [1 ]
Okuwaki, Kosuke [1 ]
Nishiyama, Ryo [2 ]
Kida, Mitsuhiro [1 ]
Imaizumi, Hiroshi [1 ]
Iwai, Tomohisa [1 ]
Yamauchi, Hiroshi [1 ]
Kaneko, Toru [1 ]
Hasegawa, Rikiya [1 ]
Miyata, Eiji [1 ]
Kumamoto, Yusuke [2 ]
Koizumi, Wasaburo [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Gastroenterol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520375, Japan
[2] Kitasato Univ, Sch Med, Dept Surg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520375, Japan
关键词
Biliary tract cancer; Chemotherapy; Conversion surgery; Pathological complete response; BILIARY-TRACT CANCER; NAIVE JAPANESE PATIENTS; NAB-PACLITAXEL; PANCREATIC-CANCER; PLUS GEMCITABINE; PHASE I/II; CHEMOTHERAPY; COMBINATION; MULTICENTER; FOLFIRINOX;
D O I
10.1007/s12328-019-00972-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The patient was a 69-year-old female with a chief complaint of yellow staining of her urine. A detailed physical examination and laboratory tests were carried out, and as a result, her condition was diagnosed as unresectable advanced extrahepatic cholangiocarcinoma with liver metastases. Chemotherapy using gemcitabine + cisplatin was initiated, and computed tomography after six cycles revealed that the liver metastases had disappeared, and that a partial response was achieved in the primary tumor. After tan cycles, a pylorus-preserving pancreaticoduodenectomy was performed as conversion surgery, and as a result, a pathological complete response was achieved in the primary tumor. After the primary lesion was resected, we were able to start an adjuvant chemotherapy immediately. Approximately 19 months have passed since the surgery, and the patient is currently alive and recurrence-free. If an improvement of the outcomes of chemotherapy in unresectable advanced biliary tract carcinomas is achieved in the future, there could be an increase in the number of treatment-responsive cases like the one reported in this study. Accumulating a large number of cases successfully treated by conversion surgery, and conducting a detailed analysis of the postoperative course, may help design adequate treatment strategies.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 23 条
[1]   Fibroblast Growth Factor Receptor 2 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Cholangiocarcinoma [J].
Arai, Yasuhito ;
Totoki, Yasushi ;
Hosoda, Fumie ;
Shirota, Tomoki ;
Hama, Natsuko ;
Nakamura, Hiromi ;
Ojima, Hidenori ;
Furuta, Koh ;
Shimada, Kazuaki ;
Okusaka, Takuji ;
Kosuge, Tomoo ;
Shibata, Tatsuhiro .
HEPATOLOGY, 2014, 59 (04) :1427-1434
[2]   Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Monitor Clinical Outcomes in Patients Treated With Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer [J].
Choi, Minsig ;
Heilbrun, Lance K. ;
Venkatramanamoorthy, Raghu ;
Lawhorn-Crews, Jawana M. ;
Zalupski, Mark M. ;
Shields, Anthony F. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (03) :257-261
[3]   FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer [J].
Conroy, Thierry ;
Desseigne, Francoise ;
Ychou, Marc ;
Bouche, Olivier ;
Guimbaud, Rosine ;
Becouarn, Yves ;
Adenis, Antoine ;
Raoul, Jean-Luc ;
Gourgou-Bourgade, Sophie ;
de la Fouchardiere, Christelle ;
Bennouna, Jaafar ;
Bachet, Jean-Baptiste ;
Khemissa-Akouz, Faiza ;
Pere-Verge, Denis ;
Delbaldo, Catherine ;
Assenat, Eric ;
Chauffert, Bruno ;
Michel, Pierre ;
Montoto-Grillot, Christine ;
Ducreux, Michel .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1817-1825
[4]  
EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335
[5]   Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer Patients Treated with Gemcitabine Plus Cisplatin Combination Therapy Followed by Radical Surgery [J].
Kato, Atsushi ;
Shimizu, Hiroaki ;
Ohtsuka, Masayuki ;
Yoshitomi, Hideyuki ;
Furukawa, Katsunori ;
Takayashiki, Tsukasa ;
Nakadai, Eri ;
Kishimoto, Takashi ;
Nakatani, Yukio ;
Yoshidome, Hiroyuki ;
Miyazaki, Masaru .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 :S1093-S1099
[6]   Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study [J].
Lee, Jeeyun ;
Park, Se Hoon ;
Chang, Heung-Moon ;
Kim, Jun Suk ;
Choi, Hye Jin ;
Lee, Myung Ah ;
Jang, Joung Soon ;
Jeung, Hei Cheul ;
Kang, Jung Hun ;
Lee, Hyun Woo ;
Shin, Dong Bok ;
Kang, Hye Jin ;
Sun, Jong-Mu ;
Park, Joon Oh ;
Park, Young Suk ;
Kang, Won Ki ;
Lim, Ho Yeong .
LANCET ONCOLOGY, 2012, 13 (02) :181-188
[7]   A Case of Common Bile Duct Cancer That Completely Responded to Combination Chemotherapy of Gemcitabine and TS-1 [J].
Lim, Joo Hyun ;
Ryu, Ji Kon ;
Choi, Yoon Jin ;
Kwon, Jieun ;
Kim, Ji Yeon ;
Lee, Yun Bin ;
Kim, Jae Hwan ;
Yoon, Won Jae ;
Kim, Yong Tae ;
Yoon, Yong Bum .
GUT AND LIVER, 2013, 7 (03) :371-376
[8]   Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan [J].
Miyakawa, Shuichi ;
Ishihara, Shin ;
Horiguchi, Akihiko ;
Takada, Tadahiro ;
Miyazaki, Masaru ;
Nagakawa, Takukazu .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2009, 16 (01) :1-7
[9]   Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT) [J].
Mizusawa, Junki ;
Morizane, Chigusa ;
Okusaka, Takuji ;
Katayama, Hiroshi ;
Ishii, Hiroshi ;
Fukuda, Haruhiko ;
Furuse, Junji .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (04) :385-388
[10]   Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805) [J].
Morizane, Chigusa ;
Okusaka, Takuji ;
Mizusawa, Junki ;
Takashima, Atsuo ;
Ueno, Makoto ;
Ikeda, Masafumi ;
Hamamoto, Yasuo ;
Ishii, Hiroshi ;
Boku, Narikazu ;
Furuse, Junji .
CANCER SCIENCE, 2013, 104 (09) :1211-1216